Structures of YAP protein domains reveal promising targets for development of new cancer drugs - Wikidata - wikimedia - TriplyDB

Structures of YAP protein domains reveal promising targets for development of new cancer drugs

Structures of YAP protein domains reveal promising targets for development of new cancer drugs

http://www.wikidata.org/entity/Q24612471

about

Mst1 and Mst2 kinases: regulations and diseases Regulation of TAZ in cancer Emerging role of Hippo pathway in gastric and other gastrointestinal cancers Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5 Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy DLG5 in cell polarity maintenance and cancer development Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2 Fluid shear stress activates YAP1 to promote cancer cell motility Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector PML Surfs into HIPPO Tumor Suppressor Pathway.Emerging roles of TEAD transcription factors and its coactivators in cancers Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.Splice variant insertions in the C-terminus impairs YAP's transactivation domain.Regulation of the Hippo pathway and implications for anticancer drug development.Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase.Structural dissection of Hippo signaling.G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer.YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma.Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.β-catenin-mediated YAP signaling promotes human glioma growth.Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: a new strategy to improve immunotherapy efficacy?MDCK cells expressing constitutively active Yes-associated protein (YAP) undergo apical extrusion depending on neighboring cell status.Dual roles of yes-associated protein (YAP) in colorectal cancer.The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences.cAMP response element-binding protein and Yes-associated protein form a feedback loop that promotes neurite outgrowth.The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ.PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression.

P2860

Q22001145-8A02938B-A6F7-4A78-958B-FC43D826C2AB Q26740462-003D0040-9F4B-4ACF-8B7B-255A7B9C2C6C Q26774473-8E643B8E-7DAF-422A-BC00-23B9624D9B80 Q27679790-B21ADCC2-2266-4588-8E78-651285DF56DC Q28078129-A60D15C3-9AEF-4CE6-9B2C-C0475B1B51B0 Q28241647-2418B0E8-6539-4791-B48A-83D6129C20FF Q28312142-693CBB3C-E79F-4151-9391-7F3B19D502B1 Q30835797-39463F58-BD2C-4056-886A-141DA87C0339 Q33700457-59D8BAB0-C03E-4DF5-85A7-BC27DEAD7C9F Q33819083-4216A587-CF0D-4DA7-A2A9-9F735D12E4D7 Q34246014-15EDC0A2-A190-41DA-9CF2-C2B19414F237 Q35879056-1FC8DED3-3B42-4DD7-95F5-163FA7FE5965 Q36504430-E08CDB3A-210E-42B3-A1E9-203BD8B29E11 Q36647912-DC1325AA-3B75-4D47-94F8-C09ECEDFD159 Q36901489-184DF629-30DC-41CA-B7ED-E21EF5D5E90B Q37262910-271C1947-174C-4EB0-BAF4-1A70AC71E295 Q37373544-03AF5505-4E92-4F94-8886-657D573E3DDB Q37524477-41FD0936-8B15-47C3-80ED-5288EED4C492 Q37593084-00A0F209-7536-404B-BC97-B0E07A39F39B Q37609446-8623D71A-BD5E-4122-93B2-BF91F4EF5535 Q37701398-8CEA44CF-73C6-4FED-80B0-DA09E7694BDD Q37716882-FEEC6AE5-81FD-4D37-95BB-BE20CBD17647 Q38283342-E384F28F-3898-4DB1-8AE1-CE39744FEFDE Q38285829-188E4C8C-9A25-452D-9B55-A797CE84EDDC Q38800001-DCDECFC5-B086-4A3D-81EE-DBD1322A12D2 Q38901912-844C5D5C-544C-4F12-8E1F-675D4B4B4F65 Q39062242-C9DCC052-F3A2-46FB-A257-72013C522C6E Q39654967-A055132F-699F-469F-817D-AAC450626F01 Q40898525-77341E57-7E90-4523-8300-CF96E5F98AE7 Q41392084-DA122F8D-F4E9-4F36-9C4B-76BE096A55E4 Q41971317-4D120A7B-20C9-46B5-8710-C0723598DBF1 Q42199985-64AE4E1B-CA37-41BD-9B3C-ED6F43402B6B Q42341966-50A0A8F5-884D-458E-BEBA-352CF6A1ABF4 Q42578908-D0930323-4330-4A35-9C5A-85BD25D1CE4C Q43651454-2E841D13-7624-449E-9A2B-DD7EC6870F94 Q44811374-6569D7E0-60F2-4693-A526-60C4FD57BF06 Q47103450-A66CEBA1-EC08-487C-9AA7-B490E84ADE09 Q47689880-9D2015D2-0572-4990-9816-E99A63EF75BB Q50308570-A1FCB4C1-8663-4DDC-A7BE-F17BB1C611AF Q52579777-362D1793-A1D0-424D-A652-9B7E311BA86F

P2860

Structures of YAP protein domains reveal promising targets for development of new cancer drugs

http://www.wikidata.org/entity/Q24612471

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Structures of YAP protein doma ...... evelopment of new cancer drugs

@ast

Structures of YAP protein doma ...... evelopment of new cancer drugs

@en

Structures of YAP protein doma ...... evelopment of new cancer drugs

@nl

type

label

Structures of YAP protein doma ...... evelopment of new cancer drugs

@ast

Structures of YAP protein doma ...... evelopment of new cancer drugs

@en

Structures of YAP protein doma ...... evelopment of new cancer drugs

@nl

prefLabel

Structures of YAP protein doma ...... evelopment of new cancer drugs

@ast

Structures of YAP protein doma ...... evelopment of new cancer drugs

@en

Structures of YAP protein doma ...... evelopment of new cancer drugs

@nl

P1433

Q24612471-225947FF-12E0-4B55-877C-903A0C1690FA

P1476

Q24612471-CEC33725-B0EE-4D9A-A24D-FAA332D63242

P2093

Q24612471-5E40EA43-1319-41B0-AF8D-5601F593A684

Q24612471-9900C616-2A6C-4BF5-953C-AEDF1857A315

Q24612471-99245BED-4C69-4948-B470-34A856180294

P2860

Q24612471-00F2155B-899B-4CEB-8A72-E4F00BDE0BFF

Q24612471-040F1A50-CD5E-46BA-BB5D-3F1086247AD2

Q24612471-09013009-FA2B-4DB3-98D1-CBEEDE3A5B54

Q24612471-0FB23B29-F54C-4065-9AFE-7511BB7E013F

Q24612471-10397BD0-E717-4CFB-803B-8F676916260A

Q24612471-22EA37A5-4B6E-459C-A03A-8B39D9104FF4

Q24612471-24D829F0-4DB0-4C4C-B5EE-91B098E95D5B

Q24612471-25899683-2C5A-4975-A9BE-58543DA6379C

Q24612471-25C8CF99-E396-4B11-BF83-9BB193F89A43

Q24612471-26108C86-EDF0-4D3A-A10A-765F51FA5A3F

P304

Q24612471-ABA6939E-E39A-4FFE-B131-799D18F9BCF4

P31

Q24612471-732CFE5A-427B-46F6-8124-26DB113D48D2

P3181

Q24612471-2C5895AC-B343-4D99-A44B-34AF0AF59DDD

P356

Q24612471-E8AEBC1D-73EC-4E89-8684-CE3620BDB453

P407

Q24612471-83537866-DD55-4952-9647-3E473FC33115

P433

Q24612471-BF1BEDFD-AC41-4E77-B191-DE0AF8C344A0

P478

Q24612471-99920877-9ACF-430D-9292-30C967AE3566

P577

Q24612471-FE56D280-4820-4203-A688-8B23AAC0A7F2

P698

Q24612471-D21C199C-8638-4325-B720-101BFB04A7C0

P921

Q24612471-0ECE768D-D756-4D7F-A093-07F69BC4952A

Q24612471-4EB2575B-B90C-4C5A-87BA-5CEEF710E828

P932

Q24612471-D96A20F0-C68D-4E9F-98A9-462A9FA4755C

P3181

P356

J.SEMCDB.2012.05.002

P1433

Seminars in Cell & Developmental Biology

P1476

Structures of YAP protein doma ...... evelopment of new cancer drugs

@en

P2093

Amjad Farooq

http://www.w3.org/2001/XMLSchema#string

Denis C Shields

http://www.w3.org/2001/XMLSchema#string

Marius Sudol

http://www.w3.org/2001/XMLSchema#string

P2860

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ

Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules

The hippo signaling pathway in development and cancer

Hippo pathway-independent restriction of TAZ and YAP by angiomotin

TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing

P304

827-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

612786

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.SEMCDB.2012.05.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22609812

http://www.w3.org/2001/XMLSchema#string

P921

protein structure

P932

3427467

http://www.w3.org/2001/XMLSchema#string